Rethinking screening for breast cancer and prostate cancer.

作     者：Jeanine Genkinger 

作者机构：Georgetown University Medical CenterUnited States of America Public Health&Epidemiology 

出 版 物：《中国肿瘤临床》 (Chinese Journal of Clinical Oncology)

年 卷 期：2010年第37卷第2期

页      面：124-125页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Rethinking screening for breast cancer and prostate cancer than over 

摘      要：For a screening test to be optimal, once thescreening test is implemented, an initial increasein cancer incidence is expected and then a returnto prescreening rates should occur. Over time, thetest should result in an increase in incidences inlocalized cancers but a decrease in incidences inregional cancers. However, as this study shows,use of mammography for breast cancer screeningand prostate-specific antigen (PSA) evaluationfor prostate cancer screening represent less thanoptimal tests, and more intermediate case scenariosin which the incidences of both cancers haveincreased substantially while the incidences ofregional cancers have only slightly declined overtime.